0000000001275517

AUTHOR

C. Sferrazza

showing 7 related works from this author

Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia

2006

Adult thalassemic patients have reduced bone mass due to disturbances in several different mechanisms affecting bone turnover. To determine if vitamin D deficiency contributes to the low bone mass of adult thalassemic subjects, we studied serum 25-OH-vitamin D levels in 90 patients (age ranging between 21 and 48 years) affected with thalassemia major (TM) and 35 (age 21-56 years) with thalassemia intermedia (TI). TM patients had been receiving regular transfusions from the age of 2 years and had increased serum ferritin, glutamic oxalacetic transaminase, glutamic piruvic transaminase as well as low bone density (L1-L4 Z score -2.07 +/- 0.2). TI patients did not receive transfusions, but the…

AdultMaleVitaminmedicine.medical_specialtyHistologyBone densityPhysiologyEndocrinology Diabetes and MetabolismThalassemiavitamin D deficiencyTransaminaseBone remodelingchemistry.chemical_compoundBone DensityInternal medicineVitamin D and neurologyHumansMedicineVitamin DThalassemia majorbusiness.industryMiddle Agedmedicine.diseaseUrinary calciumEndocrinologychemistryParathyroid HormoneThalassemiaFemalebusinessBone
researchProduct

In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation.

2006

In this study we have evaluated the in vitro effects of four different aminobisphosphonates, alendronate, risedronate, neridronate and zoledronate, on Vγ9Vδ2 T cell activation and differentiation. All tested aminobisphosphonates induce an IL-2-dependent activation and expansion of Vγ9Vδ2 T lymphocytes in primary PBMC cultures of healthy donors. Most notably, they also determine a different distribution of Vγ9Vδ2 T cell subsets, with decrease of Tnaive and TCM cells and increase of TEM and TEMRA Vγ9Vδ2 cells, indicating that in vitro treatment with aminobisphosphonates induces Vγ9Vδ2 T lymphocytes to differentiate towards an effector/cytotoxic phenotype. Accordingly, Vγ9Vδ2 T lymphocytes cu…

Cell SurvivalT cellT-LymphocytesImmunologyLymphocyte ActivationPeripheral blood mononuclear cellMonocytesFlow cytometry03 medical and health sciencesInterferon-gamma0302 clinical medicinemedicineImmunology and AllergyCytotoxic T cellHumansCytotoxicityImage CytometryPharmacologymedicine.diagnostic_testBone Density Conservation AgentsDiphosphonatesChemistryEffectorCell DifferentiationFlow CytometryPhenotypeIn vitromedicine.anatomical_structure030220 oncology & carcinogenesisCancer research030215 immunologyInternational journal of immunopathology and pharmacology
researchProduct

FokI Polymorphism of the Vitamin D Receptor Gene Correlates with Parameters of Bone Mass and Turnover in a Female Population of the Italian Island of…

2005

One of the most promising genetic approaches to dissecting a multifactorial disease is represented by genetically isolated population studies. We studied a genetic marker in a cohort of women living on the Mediterranean island of Lampedusa, a geographically isolated population. Lampedusa, located between the African coast and Sicily, consists of a young genetic isolate (<20 generations) with an exponential growth in the last generations. We analyzed the association between the FokI vitamin D receptor (VDR) gene polymorphism, previously proposed as a predictor of bone mass, with parameters of bone mass and turnover in a cohort of pre- and postmenopausal women living on Lampedusa. In 424 wome…

medicine.medical_specialtyGenotypeBone densityEndocrinology Diabetes and MetabolismOsteoporosisCalcitriol receptorBone and BonesWhite PeopleCohort StudiesFokI polymorphism of the vitamin DEndocrinologyGene FrequencyBone DensityRisk FactorsInternal medicineGenotypemedicineHumansOrthopedics and Sports MedicineAllele frequencyOsteoporosis PostmenopausalUltrasonographyPolymorphism GeneticbiologyExonsMiddle Agedmedicine.diseaseFokIPostmenopauseEndocrinologyItalyPremenopauseOsteocalcinbiology.proteinReceptors CalcitriolFemaleGene polymorphismCalcified Tissue International
researchProduct

Two novel mutations at exon 8 of the Sequestosome 1 (SQSTM1) gene in an Italian series of patients affected by Paget's disease of bone (PDB).

2003

PDB is genetically heterogeneous. Mutations of the sequestosome1 gene have been reported in sporadic and familial forms of Paget's in patients of French Canadian and British descent. Mutational analyses in different ethnic groups are needed to accurately investigate hereditary diseases. We describe two novel mutations of sequestosome1 in 62 Italian sporadic patients, confirming the role of the encoded protein in this disorder. Introduction: Paget's disease of bone (PDB) is a relatively common disease of bone metabolism reported to affect up to 3% of whites over 55 years of age. The disorder is genetically heterogeneous, and at present, there is scientific evidence that at least eight differ…

AdultMaleEndocrinology Diabetes and MetabolismPopulationExonSequestosome 1GenotypeSequestosome-1 ProteinmedicineHumansOrthopedics and Sports MedicineeducationAdaptor Proteins Signal TransducingAgedDNA PrimersGeneticsAged 80 and overeducation.field_of_studyBase SequenceGenetic heterogeneitybusiness.industryProteinsExonsMiddle Agedmedicine.diseaseOsteitis DeformansPenetrancePaget's disease of boneHereditary DiseasesMutationFemalebusinessJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
researchProduct

The malnutrition in the elderly: A clinical approach

2004

Settore MED/09 - Medicina Internamalnutrition; elderlymalnutritionelderly
researchProduct

Oral pathology in untreated coeliac disease

2007

Settore MED/09 - Medicina InternaOral pathology; untreated coeliac diseaseOral pathologyuntreated coeliac disease
researchProduct

Persistence of the deficit of bone mineral density (BMD) in adult subjects with celiac disease in dietary treatment

2004

researchProduct